fluoxetine has been researched along with methamphetamine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.25) | 18.7374 |
| 1990's | 3 (9.38) | 18.2507 |
| 2000's | 15 (46.88) | 29.6817 |
| 2010's | 12 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Azmitia, EC; Berger, UV; Gu, XF | 1 |
| Trulson, ME; Trulson, VM | 1 |
| Fuller, RW; Perry, KW; Ricaurte, GA; Schuster, CR; Seiden, LS | 1 |
| Beyeler, ML; Fleckenstein, AE; Gibb, JW; Hanson, GR; Jackson, JC; Wilkins, DG | 1 |
| Tsuchiya, K | 1 |
| Batki, SL; Bradley, M; Delucchi, K; Everhart, T; Hersh, D; Jacob, P; Jones, RT; Lefkowitz, E; Mengis, M; Moon, J; Morello, L; Sexe, D; Smolar, S | 1 |
| Matuszewich, L; Yamamoto, BK | 1 |
| Baumann, MH; Rothman, RB; Zolkowska, D | 1 |
| Adair, BP; Baucum, AJ; Birdsall, E; Bitter, R; Fleckenstein, AE; Gibb, JW; Hanson, GR; Rau, KS; Riordan, JA; Volz, TJ | 1 |
| Ishii, S; Ito, T; Kaneko, Y; Kashiwa, A; Nishikawa, T; Umino, A | 1 |
| Crabbe, JC; Kliethermes, CL | 1 |
| Hagino, Y; Ikeda, K; Markou, A; Ogai, Y; Takamatsu, Y; Yamamoto, H | 1 |
| Keithley, RB; Porter, SE; Rutan, SC | 1 |
| Borycz, J; Ferré, S; Quiroz, C; Volkow, ND; Zapata, A | 1 |
| Gross, G; Groth, I; Jongen-Relo, A; Rex, A; Wicke, KM | 1 |
| Fukushima, S; Hall, FS; Hata, H; Kobayashi, H; Lesch, KP; Murphy, DL; Numachi, Y; Ohara, A; Sora, I; Uhl, GR; Watanabe, H; Yamashita, M | 1 |
| Blaugrund, E; Cohen, S; Eliash, S; Fine, T; Litinetsky, L; Speiser, Z | 1 |
| Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S | 1 |
| Ayala, ME | 1 |
| Castillo, C; Meneses, A; Rocha, L; Tellez, R | 1 |
| Gómez-Víquez, L; Meneses, A; Tellez, R | 1 |
| Gómez-Viquez, L; Liy-Salmeron, G; Meneses, A; Tellez, R | 1 |
| Bai, Y; Liu, M; Sun, YX; Wang, HL; Wang, HM; Wang, Y; Zhang, XH | 1 |
| Heilbronner, SR; Meck, WH | 1 |
| Delgermurun, D; Ito, S; Ohta, T; Otsuguro, K; Yamaguchi, S | 1 |
| Cevallos, J; DeShields, S; Izquierdo, A; Pozos, H; Rodriguez, J; Stolyarova, A; Torre, Ade L | 1 |
| Bai, Y; Gu, YH; Liu, M; Wang, HL; Wang, Y | 1 |
| Kirby, LG; Nayak, S; Rawls, SM; Reitz, AB; Tallarida, C; Yu, F; Zewde, AM | 1 |
1 review(s) available for fluoxetine and methamphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for fluoxetine and methamphetamine
| Article | Year |
|---|---|
Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis.
Topics: Adult; Amphetamine-Related Disorders; Female; Fluoxetine; Humans; Male; Methamphetamine; Single-Blind Method | 2000 |
30 other study(ies) available for fluoxetine and methamphetamine
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cocaine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
Reduction in brain serotonin synthesis rate following chronic methamphetamine administration in rats.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Benserazide; Brain; Fluoxetine; Hydroxyindoleacetic Acid; Male; Methamphetamine; Probenecid; Rats; Rats, Inbred Strains; Serotonin | 1982 |
Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine.
Topics: Animals; Caudate Nucleus; Dextroamphetamine; Dopamine; Drug Interactions; Fluoxetine; Male; Methamphetamine; Propylamines; Putamen; Rats; Rats, Inbred Strains; Serotonin | 1983 |
Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters.
Topics: Animals; Carrier Proteins; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoxetine; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Visual Cortex | 1997 |
[Effects of methamphetamine on responsiveness to conditioned fear stress].
Topics: Animals; Benzamides; Benzazepines; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Fear; Fluoxetine; Homovanillic Acid; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Raclopride; Rats; Rats, Wistar; Salicylamides; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1999 |
Effects of chronic stress on methamphetamine-induced dopamine depletions in the striatum.
Topics: Animals; Antidepressive Agents, Tricyclic; Chronic Disease; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Male; Methamphetamine; Neostriatum; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2004 |
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrochemistry; Fluoxetine; Heart Diseases; Hydroxyindoleacetic Acid; Indicators and Reagents; Lung Diseases; Male; Methamphetamine; Microdialysis; Mitogens; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical | 2006 |
Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
Topics: Animals; Benzylamines; Data Interpretation, Statistical; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Male; Methamphetamine; Neurons; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2006 |
Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Fluoxetine; Head Movements; Locomotion; Methamphetamine; Mice; Paroxetine; Psychoses, Substance-Induced; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2007 |
Pharmacological and genetic influences on hole-board behaviors in mice.
Topics: Animals; Desipramine; Diazepam; Exploratory Behavior; Female; Fluoxetine; Male; Methamphetamine; Mice; Mice, Inbred Strains; Pentylenetetrazole; Piperazines; Selective Serotonin Reuptake Inhibitors | 2006 |
Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice.
Topics: Amphetamine-Related Disorders; Animals; Dopamine Agents; Fluoxetine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Selective Serotonin Reuptake Inhibitors | 2006 |
Development of an in vitro incubation procedure for screening of CYP2D6 intrinsic clearance.
Topics: Chromatography, Liquid; Cytochrome P-450 CYP2D6; Fluoxetine; Kinetics; Methamphetamine; Reference Standards; Spectrometry, Mass, Electrospray Ionization | 2007 |
5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.
Topics: Animals; Central Nervous System Stimulants; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fluoxetine; Male; Methamphetamine; Methylphenidate; Microdialysis; Motor Activity; Nucleus Accumbens; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 2008 |
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Investigational; Fluoxetine; Guinea Pigs; Injections, Intraperitoneal; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Swimming; Tranylcypromine | 2007 |
Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Topics: Animals; Body Temperature; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Female; Fever; Fluoxetine; Interleukin-1beta; Lethal Dose 50; Male; Methamphetamine; Mice; Mice, Knockout; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2007 |
Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
Topics: Animals; Behavior, Animal; Brain; Drug Therapy, Combination; Fluoxetine; Indans; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome | 2008 |
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2009 |
Brain serotonin, psychoactive drugs, and effects on reproduction.
Topics: Affect; Amphetamine-Related Disorders; Animals; Biological Clocks; Brain; Cognition Disorders; Depressive Disorder; Drug Interactions; Female; Fenfluramine; Fluoxetine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Obesity; Psychotropic Drugs; Reproduction; Serotonin; Serotonin Receptor Agonists; Sexual Behavior, Animal; Substance-Related Disorders; Synaptic Transmission | 2009 |
Autoradiographic study of serotonin transporter during memory formation.
Topics: Analysis of Variance; Animals; Autoradiography; Brain; Brain Mapping; Central Nervous System Stimulants; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Fluoxetine; Food Deprivation; Functional Laterality; Male; Memory; Methamphetamine; Protein Binding; Radiography; Rats; Rats, Wistar; Serotonin Plasma Membrane Transport Proteins; Up-Regulation | 2010 |
GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
Topics: Amino Acid Transport System X-AG; Amnesia; Animals; Brain; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoxetine; GABA Plasma Membrane Transport Proteins; Hippocampus; Male; Memory; Methamphetamine; Neurons; Neurotransmitter Transport Proteins; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2012 |
GABA, glutamate, dopamine and serotonin transporters expression on forgetting.
Topics: Amnesia; Animals; Conditioning, Psychological; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Excitatory Amino Acid Transporter 3; Fluoxetine; GABA Plasma Membrane Transport Proteins; Hippocampus; Male; Memory; Methamphetamine; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Up-Regulation | 2012 |
Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.
Topics: Amphetamine-Related Disorders; Animals; Antidepressive Agents, Second-Generation; Down-Regulation; Familial Primary Pulmonary Hypertension; Fluoxetine; Hypertension, Pulmonary; Lung; Male; Methamphetamine; Pulmonary Artery; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Serotonin Plasma Membrane Transport Proteins | 2013 |
Dissociations between interval timing and intertemporal choice following administration of fluoxetine, cocaine, or methamphetamine.
Topics: Animals; Behavior, Animal; Choice Behavior; Cocaine; Dopamine Uptake Inhibitors; Fluoxetine; Impulsive Behavior; Learning; Methamphetamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Perception | 2014 |
Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives.
Topics: Animals; Aorta, Thoracic; Chickens; Clomipramine; Fluoxetine; Fluvoxamine; In Vitro Techniques; Male; Methamphetamine; p-Chloroamphetamine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2016 |
Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats.
Topics: Age Factors; Animals; Animals, Newborn; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Fluoxetine; Learning; Male; Methamphetamine; Methylphenidate; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2016 |
Fluoxetine protects against methamphetamine‑induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats.
Topics: Animals; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Glutathione; Heme Oxygenase-1; Interleukin-6; Lung; Male; Methamphetamine; NF-E2-Related Factor 2; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Signal Transduction | 2017 |
PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Benzodiazepines; Carbolines; Darkness; Dose-Response Relationship, Drug; Ethanol; Fluoxetine; Lighting; Methamphetamine; Models, Animal; Odorants; Olfactory Perception; Planarians; Predatory Behavior; Psychological Tests; Psychotropic Drugs; Spatial Behavior; Time Factors | 2018 |